Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE)

Main Article Content

Daniel Shrager
Scott Guenthner
David Cohen
Haixin Zhang
Daniel Richman
Andrew Korotzer
Shikha Bansal

Keywords

Atopic Dermatitis, Biologic, Dupilumab, Baseline Characteristics

Abstract

Abstract not available.

References

1. Macdonald LE, et al. Proc Natl Acad Sci U S A. 2014;111:5147-52.

2. Murphy AJ, et al. Proc Natl Acad Sci U S A. 2014;111:5153-8.

3. Blauvelt A, et al. Lancet. 2017;389:2287-303.

4. de Bruin-Weller M, et al. Br J Dermatol. 2018;178:1083-101.

5. Simpson EL, et al. N Engl J Med. 2016;375:2335-48.

6. Beck LA, et al. Am J Clin Dermatol. 2020;21:567-77.